FDA Approves Intravenous Formulation Of Pfizer's Revatio (Sildenafil) For Treatment Of Pulmonary Arterial Hypertension
FDA Approves Intravenous Formulation Of Pfizer's Revatio (Sildenafil) For Treatment Of Pulmonary Arterial Hypertension
Reuters Key Development - 35 minutes ago
